Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Von Willebrand disease in the elderly].
Itzhar-Baïkian N, Veyradier A, Dillinger JG, Stepanian A, Pautas É, Siguret V. Itzhar-Baïkian N, et al. Among authors: stepanian a. Rev Prat. 2018 Dec;68(10):1125-1131. Rev Prat. 2018. PMID: 30869223 French.
Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG): Case report and brief review of the literature.
Lefrère B, Stepanian A, Charles P, Foulon-Pinto G, Béranger N, Alhenc-Gelas M, Drouet L, Siguret V. Lefrère B, et al. Among authors: stepanian a. Thromb Res. 2019 Jun;178:75-78. doi: 10.1016/j.thromres.2019.04.010. Epub 2019 Apr 9. Thromb Res. 2019. PMID: 30991241 Review. No abstract available.
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
Jourdi G, Delrue M, Stepanian A, Valaize J, Foulon-Pinto G, Demagny J, Duchemin J, Nedelec-Gac F, Darnige L, Curis E, Delavenne X, Gaussem P, Siguret V, Gouin-Thibault I. Jourdi G, et al. Among authors: stepanian a. Thromb Res. 2019 Dec;184:86-91. doi: 10.1016/j.thromres.2019.11.001. Epub 2019 Nov 5. Thromb Res. 2019. PMID: 31710863 Free article.
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Voicu S, Delrue M, Chousterman BG, Stépanian A, Bonnin P, Malissin I, Deye N, Neuwirth M, Ketfi C, Mebazaa A, Siguret V, Mégarbane B. Voicu S, et al. Among authors: stepanian a. Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9161-9168. doi: 10.26355/eurrev_202009_22866. Eur Rev Med Pharmacol Sci. 2020. PMID: 32965009 Free article.
127 results